Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?
Date
2018-06
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Publishing Group
Abstract
Description
Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
Keywords
Rheumatology
Citation
İnanç, N. vd. (2018). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Annals of the Rheumatic Diseases, 77(Supplement 2), 611-612.